CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach fights skin cancer before the knife
Disease control OngoingThis study is testing if giving the immunotherapy drug cemiplimab to patients before their tumor removal surgery is safe and helps control their cancer. It is for adults with early-stage Merkel cell carcinoma or locally advanced squamous cell carcinoma who are scheduled for surge…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test new 'In-Situ' cancer vaccine strategy
Disease control OngoingThis early-stage trial is testing the safety of a new combination treatment for people with advanced cancers that have spread and cannot be removed by surgery. Doctors inject immune-stimulating drugs directly into a tumor, then give a small dose of radiation to that same spot. Th…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a quick workout before treatment supercharge your Body's cancer fight?
Disease control OngoingThis small, early-stage study is testing if doing 30 minutes of moderate exercise right before standard immunotherapy can help the treatment work better against certain skin cancers. Researchers will enroll 22 adults with melanoma, squamous cell carcinoma, or Merkel cell carcinom…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug trial offers hope for advanced skin cancer patients
Disease control OngoingThis study is testing an investigational drug called INCB099280 in people with advanced squamous cell carcinoma, a type of skin cancer that has spread or cannot be treated with surgery or radiation. The main goals are to see if the drug is safe and if it can shrink tumors. It inv…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug aims to stop aggressive skin Cancer's return
Disease control OngoingThis study is testing whether a drug called cemiplimab can prevent a serious type of skin cancer from returning after initial treatment. It involves 415 people with high-risk cutaneous squamous cell carcinoma who have already had surgery and radiation. Participants receive either…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New weapon against cancer enters human testing
Disease control OngoingThis is an early-stage study testing a new antibody drug called IMT-009 in people with advanced solid tumors or lymphomas that have stopped responding to standard treatments. The main goals are to find a safe dose, understand the side effects, and see if the drug helps shrink tum…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC